Objectives: 1. Describe the hemoglobin-oxygen dissociation curve as it relates to PaO2 levels and ability to maintain O2 saturation 2. Recall how to use blood gases to get STAT chemistry results in an emergency situation

Objectives: 1. Describe the evidence behind CMV treatment and prevention in immunocompetent patients 2. Recall the cohort of immunocompetent patients where CMV treatment is reasonable

Objectives: 1. Describe an order review process to prevent unsafe use of fentanyl patches in hospitalized patients 2. Recall the contraindications to fentanyl patch use

Objectives: 1. Describe the type of patient who is likely to respond to treatment with sumatriptan for migraine 2. Recall the lower dose of sub qsumatriptan that can be used in patients that do not tolerate the 6 mg dose

Objectives: 1. Define Non-Massive (Non-Life-Threatening) Hemoptysis 2. Recall the dosing of nebulized tranexamic acid for this indication

Objectives: 1. Describe the importance of collecting cultures before the first dose of antibiotics 2. Recall what parameters to consider when determining contamination vs infection for blood culture results

Objectives: 1. Describe the clinical presentation of Non-Heparin Drug-Induced Thrombocytopenia 2. Recall the expected time course for recovery of platelets from Non-Heparin Drug-Induced Thrombocytopenia

Objectives: 1. Describe the pain, sedation, and delirium scales with the best reliability 2. Recall why the Ramsay sedation scale does not correlate well with the actual depth of sedation

Objectives: 1. Describe the 4T score and it’s role in the diagnosis of heparin-induced thrombocytopenia 2. Recall the options to treat heparin-induced thrombocytopenia

Objectives: 1. Describe how to obtain susceptibility data that has been suppressed by the micro lab 2. Recall the most common types of susceptibility tests and whether they provide an exact MIC

Objectives: 1. Describe the safety profile of droperidol in terms of torsades and QTc prolongation 2. Recall the starting dose of droperidol for agitation, migraine, and nausea in an ED population

Objectives: 1. Describe the reasons why agitated delirium might require treatment in the ICU 2. Recall the classes of medications with published data for agitated delirium in ICU patients